Heart ultrasound gets a boost: new contrast agent aims for sharper images
NCT ID NCT06815627
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This Phase 3 trial tests whether NH002, a contrast agent made of tiny gas-filled microspheres, can improve the quality of heart ultrasound images in people with heart disease. Participants receive NH002 through an IV before a standard echocardiogram. The study compares the clarity of heart chamber borders and overall image quality with and without the contrast agent. The goal is to see if NH002 helps doctors get clearer, more reliable images of the heart.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NH002 (Perflutren Lipid Microspheres) Injectable Suspension
- What this could lead to
- If successful, NH002 could make heart ultrasounds more accurate, helping doctors see heart structure and function better without more invasive tests.
- What could go wrong
- This is a Phase 3 trial with 150 participants, so results may not apply to everyone. The contrast agent may cause side effects like allergic reactions or temporary discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cathay General Hospital
Taipei, 106438, Taiwan
-
China Medical University Hospital
Taichung, 404327, Taiwan
-
Keelung Chang Gung Memorial Hospital & Lovers Lake Branch
Keelung, 204201, Taiwan
-
MacKay Memorial Hospital
Taipei, 104217, Taiwan
-
National Taiwan University Hospital Hsin-Chu Branch
Zhubei, 302058, Taiwan
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive heart biobank aims to unlock genetic secrets of cardiovascular disease
- New heart MRI could slash scan time and hassle
- Can a simple exercise test tell ME/CFS apart from heart disease?
- No more fasting before heart catheterization? trial challenges standard practice
- New study probes breathing muscle weakness in kids